Publication date: Mar 05, 2026
Melanoma causes over 80% of skin cancer-related deaths, with conventional therapies hampered by its aggressiveness, metastasis, and drug resistance. Noninvasive, biocompatible strategies are promising for next-generation cancer treatments. Herein, we developed a soft, stretchable laser-induced graphene (LIG)-Cu/PDMS patch, consisting of CuO-embedded LIG (active component) and biocompatible PDMS (flexible matrix). Chemically inert and breathable, the patch minimizes toxic side effects. Upon photothermal activation, it releases Cu that accumulates in melanoma tissue. In a mouse model, two 1-h phototherapy sessions achieved effective tumor suppression within 10 days. Mechanistically, the patch enhances reactive oxygen species production, inducing apoptosis, cuproptosis, and ferroptosis. It also inhibits tumor invasion/metastasis and boosts antitumor immunity, with stable performance enabling multiple uses (energy-efficient and environmentally sustainable). This work demonstrates graphene-based materials’ potential in cancer therapy via synergistic activation of multiple cell death pathways and efficacy in low-temperature phototherapy, expanding graphene’s application in malignant tumor treatment and highlighting its clinical translation prospects.
Open Access PDF
| Concepts | Keywords |
|---|---|
| Cancer | cuproptosis |
| Drug | ferroptosis |
| Efficient | laser-induced graphene (LIG) |
| Laser | low-temperature phototherapy |
| Phototherapy | melanoma |